The scientific and clinical communities have both experienced several harsh lessons on clinical care management and drug development during the COVID-19 pandemic. Here, we discuss several key lessons learned and describe a framework within which our two communities can work together and invest in to improve future pandemic responses.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452505 | PMC |
| http://dx.doi.org/10.1016/j.cell.2021.09.025 | DOI Listing |
Publication Analysis
Top Keywords
harsh lessons
8
emergency drug
4
drug pandemic
4
pandemic harsh
4
lessons covid-19
4
covid-19 scientific
4
scientific clinical
4
clinical communities
4
communities experienced
4
experienced harsh
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!